Chan JK - Search Results

1

Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.

Swisher EM, Harrell MI, Norquist BM, Walsh T, Brady M, Lee M, Hershberg R, Kalli KR, Lankes H, Konnick EQ, Pritchard CC, Monk BJ, Chan JK, Burger R, Kaufmann SH, Birrer MJ. Swisher EM, et al. Among authors: chan jk. JAMA Oncol. 2016 Mar;2(3):370-2. doi: 10.1001/jamaoncol.2015.6053. JAMA Oncol. 2016. PMID: 26847329 Free PMC article.

2

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.

Chan JK, Lin YG, Monk BJ, Tewari K, Bloss JD, Berman ML. Chan JK, et al. Obstet Gynecol. 2001 May;97(5 Pt 1):707-11. Obstet Gynecol. 2001. PMID: 11339920

3

Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model.

Chan JK, Monk BJ, Cuccia D, Pham H, Kimel S, Gu M, Hammer-Wilson MJ, Liaw LH, Osann K, DiSaia PJ, Berns M, Tromberg B, Tadir Y. Chan JK, et al. Gynecol Oncol. 2002 Oct;87(1):64-70. doi: 10.1006/gyno.2002.6793. Gynecol Oncol. 2002. PMID: 12468344

4

Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.

Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Chan JK, et al. Cancer. 2003 Feb 1;97(3):568-74. doi: 10.1002/cncr.11086. Cancer. 2003. PMID: 12548598 Free article.

5

HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

Chan JK, Monk BJ, Brewer C, Keefe KA, Osann K, McMeekin S, Rose GS, Youssef M, Wilczynski SP, Meyskens FL, Berman ML. Chan JK, et al. Br J Cancer. 2003 Sep 15;89(6):1062-6. doi: 10.1038/sj.bjc.6601196. Br J Cancer. 2003. PMID: 12966426 Free PMC article. Clinical Trial.

6

Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma.

Chan JK, Sugiyama V, Tajalli TR, Pham H, Gu M, Rutgers J, Monk BJ. Chan JK, et al. Gynecol Oncol. 2004 Oct;95(1):152-6. doi: 10.1016/j.ygyno.2004.07.004. Gynecol Oncol. 2004. PMID: 15385125

7

Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.

Chan JK, Pham H, You XJ, Cloven NG, Burger RA, Rose GS, Van Nostrand K, Korc M, Disaia PJ, Fan H. Chan JK, et al. Cancer Res. 2005 Apr 15;65(8):3243-8. doi: 10.1158/0008-5472.CAN-03-3013. Cancer Res. 2005. PMID: 15833856

8

Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.

Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Chan JK, et al. Gynecol Oncol. 2008 Jan;108(1):95-9. doi: 10.1016/j.ygyno.2007.08.087. Epub 2007 Oct 18. Gynecol Oncol. 2008. PMID: 17949796

9

Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?

Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS. Chan JK, et al. J Clin Oncol. 2008 Mar 20;26(9):1511-8. doi: 10.1200/JCO.2007.14.8874. Epub 2008 Feb 19. J Clin Oncol. 2008. PMID: 18285603

10

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.

Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC; Gynecologic Oncology Group. Chan JK, et al. Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390. Cancer. 2008. PMID: 18348296 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,220 results

Search Page